Hexarelin (2mg)

Molecular Formula: C₄₇H₅₈N₁₂O₆

Molecular Weight: 887.053
Sequence: L-Histidyl-2-methyl-D-tryptophyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide; {HIS}{D-2-ME-TRP}{ALA}{TRP}{d-PHE}{LYS}-NH2 

Appearance: White Freeze-dried powder

HPLC Purity: 98.58%

Bacterial Endotoxins: Less than 3 EU/mg of Hexarelin

Freeze-dried powder can be stored at -20 degree C for a year. Reconstituted solution should be kept in the refrigerator at 2-8 degree C and used as early as possible. Avoid multiple freeze-thaw cycles and exposure to frequent for lyophilized powder or reconstituted vials.

Hexarelin is a synthetic hexapeptide of the growth hormone-releasing peptide (GHRP) family with strong growth hormone (GH)-releasing activity.

Hexarelin is structurally similar to GHRP-6, with the substitution of D-Trp with its 2-methyl derivative; more stable and less toxic than GHRP-6.

Hexarelin is a peptide GH secretagogue with a potent ability to stimulate GH secretion and recently reported cardioprotective actions. However, hexarelin effects in the brain are largely unknown, and the aim of the present study was to examine the potential protective effect of hexarelin on the central nervous system after injury, as well as on caspase-3, Akt, and extracellular signal-regulated protein kinase (ERK) signaling cascades in a rat model of neonatal hypoxia-ischemia.